FDA — authorised 30 November 1998
- Application: BLA020898
- Marketing authorisation holder: GENZYME
- Status: supplemented
FDA authorised Thyrogen on 30 November 1998
Yes. FDA authorised it on 30 November 1998; FDA has authorised it.
GENZYME holds the US marketing authorisation.